{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:17:44Z","timestamp":1770279464689,"version":"3.49.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"am","delay-in-days":254,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jbspin.2022.105435","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T15:28:17Z","timestamp":1656430097000},"page":"105435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort"],"prefix":"10.1016","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-4364","authenticated-orcid":false,"given":"Shuhui","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5368-7473","authenticated-orcid":false,"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9671-5323","authenticated-orcid":false,"given":"Mingshu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijing","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8285","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2022.105435_bib0290","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: the National Health and Nutrition Examination Survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0295","doi-asserted-by":"crossref","first-page":"762820","DOI":"10.1155\/2015\/762820","article-title":"Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jbspin.2022.105435_bib0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2012-202421","article-title":"Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout","volume":"73","author":"Perez-Ruiz","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0305","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2022.105435_bib0310","first-page":"18","article-title":"Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care","author":"Choi","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0315","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2022.105435_bib0320","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0325","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0330","doi-asserted-by":"crossref","first-page":"e017542","DOI":"10.1136\/bmjopen-2017-017542","article-title":"Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis","volume":"8","author":"Yin","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.jbspin.2022.105435_bib0335","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00296-017-3746-x","article-title":"The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study","volume":"37","author":"Yin","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2022.105435_bib0340","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.amjmed.2018.11.011","article-title":"Adherence and outcomes with urate-lowering therapy: a site-randomized trial","volume":"132","author":"Mikuls","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2022.105435_bib0345","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10067-014-2823-8","article-title":"Adherence and persistence to urate-lowering therapies in the Irish setting","volume":"35","author":"McGowan","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0350","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0355","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims","volume":"31","author":"Riedel","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0360","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jbspin.2022.105435_bib0365","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc14-2098","article-title":"Determinants of adherence to diabetes medications: findings from a large pharmacy claims database","volume":"38","author":"Kirkman","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jbspin.2022.105435_bib0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2022.105435_bib0375","first-page":"39","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0380","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/hr.2015.23","article-title":"Association between the markers of metabolic acid load and higher all-cause and cardiovascular mortality in a general population with preserved renal function","volume":"38","author":"Park","year":"2015","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jbspin.2022.105435_bib0385","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2022.105435_bib0390","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jbspin.2022.105435_bib0395","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2011.05.010","article-title":"Treatment adherence in patients with gout","volume":"78","author":"Reach","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2022.105435_bib0400","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1097\/MD.0000000000008532","article-title":"Adherence to gout management recommendations of Chinese patients","volume":"96","author":"Sheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0405","first-page":"575","article-title":"Nurse-led care is preferred over GP-led care of gout and improves gout outcomes: results of Nottingham Gout Treatment Trial follow-up study","volume":"59","author":"Fuller","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0410","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jbspin.2022.105435_bib0415","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/ijcp.12604","article-title":"Allopurinol adherence among patients with gout: an Italian general practice database study","volume":"69","author":"Mantarro","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jbspin.2022.105435_bib0420","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2215\/CJN.10771016","article-title":"Effect of uric acid lowering on renin-angiotensin-system activation and ambulatory BP: a randomized controlled trial","volume":"12","author":"McMullan","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0425","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/art.41751","article-title":"Urate lowering for blood pressure control in adults: another nail in the coffin?","volume":"73","author":"Roddy","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0430","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/art.41749","article-title":"Effect of serum urate lowering with allopurinol on blood pressure in young adults: a randomized, controlled, crossover trial","volume":"73","author":"Gaffo","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0435","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0440","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1742395310378761","article-title":"Patients and providers view gout differently: a qualitative study","volume":"6","author":"Harrold","year":"2010","journal-title":"Chronic Illn"},{"key":"10.1016\/j.jbspin.2022.105435_bib0445","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/ken457","article-title":"Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study","volume":"48","author":"Schumacher","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0450","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s40520-013-0031-z","article-title":"Chronic gout in the elderly","volume":"25","author":"Bolzetta","year":"2013","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jbspin.2022.105435_bib0455","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/RHU.0000000000000127","article-title":"Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout","volume":"20","author":"Aati","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0460","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3899\/jrheum.181214","article-title":"Are target urate and remission possible in severe gout? A five-year cohort study","volume":"47","author":"Alvarado-de la Barrera","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0465","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2022.105435_bib0470","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2022.105435_bib0475","first-page":"17","article-title":"Renal function in gout: long-term treatment effects of febuxostat","author":"Whelton","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0480","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0485","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","article-title":"Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial","volume":"72","author":"Kimura","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0490","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-018-2051-2","article-title":"Comparison of renoprotective effects of febuxostat and allopurinol in hyperuricemic patients with chronic kidney disease","volume":"51","author":"Lee","year":"2019","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0495","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s10067-014-2745-5","article-title":"Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease","volume":"33","author":"Tsuruta","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0500","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s10157-018-1652-5","article-title":"The urate-lowering efficacy and safety of febuxostat versus allopurinol in Chinese patients with asymptomatic hyperuricemia and with chronic kidney disease stages 3-5","volume":"23","author":"Liu","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0505","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000330487","article-title":"Low urine pH Is a predictor of chronic kidney disease","volume":"35","author":"Nakanishi","year":"2012","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jbspin.2022.105435_bib0510","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/07435800.2010.497178","article-title":"The alkalizer citrate reduces serum uric Acid levels and improves renal function in hyperuricemic patients treated with the xanthine oxidase inhibitor allopurinol","volume":"35","author":"Saito","year":"2010","journal-title":"Endocr Res"},{"key":"10.1016\/j.jbspin.2022.105435_bib0515","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3899\/jrheum.140588","article-title":"Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system","volume":"42","author":"Rashid","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0520","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/key155","article-title":"Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)","volume":"57","author":"Scheepers","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0525","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00296-013-2935-5","article-title":"Allopurinol use in a New Zealand population: prevalence and adherence","volume":"34","author":"Horsburgh","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2022.105435_bib0530","doi-asserted-by":"crossref","first-page":"105078","DOI":"10.1016\/j.jbspin.2020.09.010","article-title":"Trends in the manifestations of 9754 gout patients in a Chinese clinical center: a 10-year observational study","volume":"88","author":"Gao","year":"2020","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2022.105435_bib0535","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00467-019-04357-w","article-title":"A cross-sectional study on uric acid levels among Chinese adolescents","volume":"35","author":"Lu","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jbspin.2022.105435_bib0540","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","article-title":"Adherence with urate-lowering therapies for the treatment of gout","volume":"11","author":"Harrold","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2022.105435_bib0545","first-page":"27","article-title":"Gout: state of the art after a decade of developments","volume":"58","author":"Pascart","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0550","doi-asserted-by":"crossref","first-page":"w20334","DOI":"10.4414\/smw.2020.20334","article-title":"The role of clinical inertia in suboptimal management of gout","volume":"150","author":"Punzi","year":"2020","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbspin.2022.105435_bib0555","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jbspin.2017.03.013","article-title":"Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study","volume":"85","author":"Maravic","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2022.105435_bib0560","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.1093\/rheumatology\/keaa923","article-title":"Dual-energy computed tomography vs ultrasound, alone or combined, for the diagnosis of gout: a prospective study of accuracy","volume":"60","author":"Singh","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2022.105435_bib0565","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2022.105435_bib0570","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.semarthrit.2021.06.009","article-title":"Identification and characterization of peripheral vascular color-coded DECT lesions in gout and non-gout patients: the VASCURATE study","volume":"51","author":"Pascart","year":"2021","journal-title":"Semin Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X22000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X22000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:28:56Z","timestamp":1761150536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X22000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1297319X22000951"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2022.105435","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palpable tophi and more comorbidities associated with adherence to urate-lowering medical therapy in a Chinese gout cohort","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2022.105435","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105435"}}